EP1933760A4 - Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices - Google Patents
Compositions and methods of administering rapamycin analogs with paclitaxel using medical devicesInfo
- Publication number
- EP1933760A4 EP1933760A4 EP06825887A EP06825887A EP1933760A4 EP 1933760 A4 EP1933760 A4 EP 1933760A4 EP 06825887 A EP06825887 A EP 06825887A EP 06825887 A EP06825887 A EP 06825887A EP 1933760 A4 EP1933760 A4 EP 1933760A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- paclitaxel
- compositions
- methods
- medical devices
- rapamycin analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Epoxy Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72708005P | 2005-10-14 | 2005-10-14 | |
US72687805P | 2005-10-14 | 2005-10-14 | |
US72719605P | 2005-10-14 | 2005-10-14 | |
US73257705P | 2005-10-17 | 2005-10-17 | |
PCT/US2006/040027 WO2007047416A2 (en) | 2005-10-14 | 2006-10-12 | Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1933760A2 EP1933760A2 (en) | 2008-06-25 |
EP1933760A4 true EP1933760A4 (en) | 2009-08-12 |
Family
ID=37962960
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20060813474 Active EP1933785B1 (en) | 2005-10-14 | 2006-08-15 | Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
EP06816907.7A Active EP1933759B1 (en) | 2005-10-14 | 2006-10-12 | Methods of administering rapamycin analogs with anti-inflammatories using medical devices |
EP06825887A Withdrawn EP1933760A4 (en) | 2005-10-14 | 2006-10-12 | Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20060813474 Active EP1933785B1 (en) | 2005-10-14 | 2006-08-15 | Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
EP06816907.7A Active EP1933759B1 (en) | 2005-10-14 | 2006-10-12 | Methods of administering rapamycin analogs with anti-inflammatories using medical devices |
Country Status (4)
Country | Link |
---|---|
EP (3) | EP1933785B1 (en) |
JP (3) | JP5285426B2 (en) |
TW (1) | TWI435724B (en) |
WO (3) | WO2007046935A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060198867A1 (en) * | 1997-09-25 | 2006-09-07 | Abbott Laboratories, Inc. | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
US8057816B2 (en) * | 1997-09-26 | 2011-11-15 | Abbott Laboratories | Compositions and methods of administering paclitaxel with other drugs using medical devices |
US7378105B2 (en) | 1997-09-26 | 2008-05-27 | Abbott Laboratories | Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens |
US7357942B2 (en) | 1997-09-26 | 2008-04-15 | Abbott Laboratories | Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens |
US8257726B2 (en) | 1997-09-26 | 2012-09-04 | Abbott Laboratories | Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
US20100030183A1 (en) * | 2004-03-19 | 2010-02-04 | Toner John L | Method of treating vascular disease at a bifurcated vessel using a coated balloon |
US8431145B2 (en) * | 2004-03-19 | 2013-04-30 | Abbott Laboratories | Multiple drug delivery from a balloon and a prosthesis |
EP2068932B1 (en) * | 2006-08-15 | 2013-11-06 | Abbott Laboratories | Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
EP2066321A2 (en) * | 2006-11-20 | 2009-06-10 | Lutonix, Inc. | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
KR20100068412A (en) * | 2007-09-04 | 2010-06-23 | 가부시키가이샤 니혼 스텐토 테크놀로지 | Stent for controlled drug release |
WO2010024898A2 (en) | 2008-08-29 | 2010-03-04 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US8092822B2 (en) * | 2008-09-29 | 2012-01-10 | Abbott Cardiovascular Systems Inc. | Coatings including dexamethasone derivatives and analogs and olimus drugs |
US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
WO2011024831A1 (en) | 2009-08-26 | 2011-03-03 | 国立大学法人九州大学 | Medical device for placement into a lumen and manufacturing method thereof |
US8951595B2 (en) | 2009-12-11 | 2015-02-10 | Abbott Cardiovascular Systems Inc. | Coatings with tunable molecular architecture for drug-coated balloon |
JP6172704B2 (en) * | 2010-01-27 | 2017-08-02 | バスキュラー・セラピーズ・インコーポレイテッド | Apparatus and method for prevention of stenosis at the site of anastomosis |
WO2011119536A1 (en) | 2010-03-22 | 2011-09-29 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
US10172789B2 (en) | 2013-01-24 | 2019-01-08 | Palvella Therapeutics Llc | Compositions for transdermal delivery of mTOR inhibitors |
CN110711056A (en) | 2014-10-28 | 2020-01-21 | 株式会社Jimro | Drug eluting stent |
WO2018129364A1 (en) | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
JP2021530463A (en) | 2018-07-02 | 2021-11-11 | パルヴェラ セラピューティクス、インク. | Anhydrous composition of mTOR inhibitor and how to use it |
US20230398266A1 (en) * | 2020-10-06 | 2023-12-14 | Ul1Sse Innovative Solutions S.R.L. | Therapeutic agent for use in local treatment of inflammation associated with atherosclerosis and/or a thrombotic state |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001087372A1 (en) * | 2000-05-12 | 2001-11-22 | Cordis Corporation | Drug combinations useful for prevention of restenosis |
US20050019404A1 (en) * | 2003-06-30 | 2005-01-27 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
WO2006116348A2 (en) * | 2005-04-26 | 2006-11-02 | Advanced Cardiovascular Systems, Inc. | Compositions for medical devices containing agent combinations in controlled volumes |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
ATE435680T1 (en) | 1997-03-31 | 2009-07-15 | Igaki Iryo Sekkei Kk | STENT FOR VESSELS |
US6015815A (en) * | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
US6890546B2 (en) * | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
US20030129215A1 (en) * | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
RU2345719C2 (en) * | 2001-01-16 | 2009-02-10 | Васкулар Терапиез, Ллс. | Method of prevention or treatment of reduction of access for vessel hemodialysis and device for its realisation and other vascular grafts |
JP4290985B2 (en) * | 2001-02-16 | 2009-07-08 | アボット ラボラトリーズ バスキュラー エンタープライゼズ リミテッド | Implant using FK506 |
US20040024448A1 (en) * | 2002-08-05 | 2004-02-05 | Chang James W. | Thermoplastic fluoropolymer-coated medical devices |
BR0314013A (en) * | 2002-09-06 | 2005-07-12 | Abbott Lab | Medical Equipment Containing Hydration Inhibitor |
US7758881B2 (en) * | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US20040236415A1 (en) * | 2003-01-02 | 2004-11-25 | Richard Thomas | Medical devices having drug releasing polymer reservoirs |
DK1638624T3 (en) * | 2003-06-19 | 2014-02-03 | Vascular Therapies Llc | Vascular closure device |
US8828416B2 (en) * | 2004-03-09 | 2014-09-09 | Cordis Corporation | Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury |
EP1735042B1 (en) * | 2004-03-19 | 2011-11-23 | Abbott Laboratories | Multiple drug delivery from a balloon and a prosthesis |
US20050208093A1 (en) * | 2004-03-22 | 2005-09-22 | Thierry Glauser | Phosphoryl choline coating compositions |
-
2006
- 2006-08-15 EP EP20060813474 patent/EP1933785B1/en active Active
- 2006-08-15 WO PCT/US2006/031879 patent/WO2007046935A2/en active Application Filing
- 2006-08-15 JP JP2008535526A patent/JP5285426B2/en active Active
- 2006-10-12 EP EP06816907.7A patent/EP1933759B1/en active Active
- 2006-10-12 WO PCT/US2006/040027 patent/WO2007047416A2/en active Application Filing
- 2006-10-12 JP JP2008535699A patent/JP5307546B2/en active Active
- 2006-10-12 JP JP2008535727A patent/JP5225849B2/en active Active
- 2006-10-12 WO PCT/US2006/040155 patent/WO2007047473A2/en active Application Filing
- 2006-10-12 EP EP06825887A patent/EP1933760A4/en not_active Withdrawn
- 2006-10-14 TW TW095137944A patent/TWI435724B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001087372A1 (en) * | 2000-05-12 | 2001-11-22 | Cordis Corporation | Drug combinations useful for prevention of restenosis |
US20050019404A1 (en) * | 2003-06-30 | 2005-01-27 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
WO2006116348A2 (en) * | 2005-04-26 | 2006-11-02 | Advanced Cardiovascular Systems, Inc. | Compositions for medical devices containing agent combinations in controlled volumes |
Non-Patent Citations (2)
Title |
---|
LEVIN ANDREW D ET AL: "Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 101, no. 25, 22 June 2004 (2004-06-22), pages 9463 - 9467, XP002532740, ISSN: 0027-8424 * |
VAN DER HOEVEN B L ET AL: "Drug-eluting stents: results, promises and problems", INTERNATIONAL JOURNAL OF CARDIOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 99, no. 1, 10 March 2005 (2005-03-10), pages 9 - 17, XP025256932, ISSN: 0167-5273, [retrieved on 20050310] * |
Also Published As
Publication number | Publication date |
---|---|
TWI435724B (en) | 2014-05-01 |
JP2009511165A (en) | 2009-03-19 |
WO2007046935A3 (en) | 2007-07-05 |
EP1933759B1 (en) | 2014-12-17 |
JP2009511205A (en) | 2009-03-19 |
EP1933759A2 (en) | 2008-06-25 |
WO2007047416A2 (en) | 2007-04-26 |
EP1933759A4 (en) | 2009-08-05 |
TW200800196A (en) | 2008-01-01 |
WO2007047473A3 (en) | 2007-08-09 |
WO2007046935A2 (en) | 2007-04-26 |
EP1933760A2 (en) | 2008-06-25 |
JP5307546B2 (en) | 2013-10-02 |
JP5285426B2 (en) | 2013-09-11 |
JP2009511195A (en) | 2009-03-19 |
EP1933785B1 (en) | 2015-04-22 |
JP5225849B2 (en) | 2013-07-03 |
EP1933785A2 (en) | 2008-06-25 |
EP1933785A4 (en) | 2009-07-29 |
WO2007047416A3 (en) | 2007-11-08 |
WO2007047473A2 (en) | 2007-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1933760A4 (en) | Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices | |
IL195237A0 (en) | Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same | |
EP2004175A4 (en) | Anti-cancer activity augmentation compounds and formulations and methods of use thereof | |
EP1877004A4 (en) | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy | |
IL195947A (en) | Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes | |
HK1154795A1 (en) | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use | |
EP1909780A4 (en) | Anti-tubercular drugs: compositions and methods | |
IL187957A0 (en) | Liquid pharmaceutical formulations of docetaxel | |
ZA200805716B (en) | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies | |
EP2200437A4 (en) | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof | |
EP2351757A4 (en) | Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof | |
ZA200802501B (en) | Indenoisoquinolinone analogs and methods of use thereof | |
IL202684A0 (en) | Anti-cd20 therapeutic compositions and methods of use thereof | |
EP2152304A4 (en) | Nanoemulsion therapeutic compositions and methods of using the same | |
IL179627A0 (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
IL202728A0 (en) | Solubilized formulation of docetaxel without tween 80 | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
IL194655A0 (en) | Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof | |
ZA200806808B (en) | Treatment of stressed patients | |
ZA200900416B (en) | Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives | |
EP2096927A4 (en) | Therapeutic compositions and methods of treatment with capsianoside-type compounds | |
IL196320A0 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
AP2009004735A0 (en) | High dose oral pharmaceutical compositions of artemether and lumefantrine | |
EP1962882A4 (en) | Compositions and methods for treatment of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080331 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090709 |
|
17Q | First examination report despatched |
Effective date: 20091023 |
|
R17C | First examination report despatched (corrected) |
Effective date: 20100607 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20101218 |